Learn more about the pediatric HGG clinical study at https://xitter.cf/t.co/N9QWzbiN3k
Florham Park, NJ
Joined March 2016
- Tweets1.5K
- Following1.2K
- Followers788
- Likes506
Cellectar Biosciences retweeted
NEW: Wisconsin-based @NMRadioisotopes will partner with @CellectarBio 🌟
This new partnership will integrate NorthStar's Ac-225 into Cellectar's proprietary PLE delivery platform for groundbreaking cancer treatments.
#Biotech #CancerResearch #WisconsinInnovation
Cellectar Biosciences retweeted
.@CellectarBio, MiBA Partner: madisonstartups.com/cellecta…
Cellectar Biosciences retweeted
.@CellectarBio Raises $103 Million in Financing: madisonstartups.com/cellecta…
Cellectar Biosciences retweeted
Listen to Dr Larry Anderson @UTSWNews & Dr Rachid Baz @MoffittNews talk about the current standards of care for Waldenstrom’s macroglobulinemia & novel therapies that are currently being evaluated.
bit.ly/31VbZZJ
@CellectarBio @MegMangin @WMIWMF
#CancerResearch #mmsm
Cellectar Biosciences retweeted
Experts at @UTSWNews & @MoffittNews talk to patient advocates at @WMIWMF & @cure_talk about novel therapies that are currently being evaluated for #Waldenstrom’s macroglobulinemia @CureTalks. Listen here: bit.ly/31VbZZJ
@MegMangin @CellectarBio
#CancerResearch #mmsm
Listen to Dr Larry Anderson @UTSWNews & Dr Rachid Baz @MoffittNews talk about the current standards of care for Waldenstrom’s macroglobulinemia & novel therapies that are currently being evaluated.
bit.ly/31VbZZJ
@CellectarBio @MegMangin @WMIWMF
#CancerResearch #mmsm
Cellectar Biosciences retweeted
The CLOVER WaM trial @CellectarBio is looking for more eligible #WM patients for Iopofosine #ClinicalTrial. Read more on how to participate: cellectar.com/clinical-studi…
#Waldenstroms #bloodcancerawareness
@CellectarBio
#CellectarBiosciences is fully committed to #Waldenstrom patients. Help our researchers by joining our #ClinicalTrial wmclinicaltrial.com $CLRB
Cellectar Biosciences retweeted
WM is a rare type of #cancer in which a protein accumulates in the blood and impairs circulation causing complications. Listen to Dr. Castillo @DanaFarber & @pdenardis talk about #Waldenstroms management, #clinicaltrials & more.
youtube.com/watch?v=3LeizRXe…
@CellectarBio @WMIWMF
Cellectar Biosciences retweeted
The National Institute of Health’s National Cancer Institute awarded a $1.98 million grant to @CellectarBio for its work on a pediatric brain tumor treatment. njbiz.com/cellectar-awarded-…
Cellectar Biosciences retweeted
.@CellectarBio Awarded $2M Grant: bit.ly/3UuS1LL
Cellectar Biosciences retweeted
Now in @BloodCancerJnl: 50% ORR with iodine isotope for RRMM #MMsm, including in prior BCMA failure. Excited to see more data!
(Caveats: Not monoTx per se, since pts also got weekly dex. N=6 dose-finding and mPFS only 3 months.)
h/t @CyclingDoctor
nature.com/articles/s41408-0… – at Seattle, WA
$CLRB Cellectar Announces Publication of Data from Its Expansion Cohort of the Phase II CLOVER-1 Study Iopofosine I-131 in Relapsed/Refractory #MultipleMyeloma in @Nature's Blood Cancer Journal bit.ly/3eLBjaJ @BloodCancerJnl #BloodCancerAwarenessMonth #mmsm #bloodcancer
Cellectar Biosciences retweeted
Don't miss @wmiwmf Virtual Ed Forum this weekend. There's still time to register for this FREE event!
Check out exhibits from some of our sponsors @CellectarBio @BeiGeneGlobal LIVE Tweet at us from the event and use #IWMFEdForum hashtag!
Register NOW: tinyurl.com/iwmfevents-ed-fo…
Cellectar Biosciences retweeted
I'm supporting the @wmiwmf Virtual Ed Forum this weekend. If you know someone effected by
#Waldenstrom send them to iwmf.com to learn more & register for this FREE event! #IWMFEdForum
Check out exhibits from some of their sponsors @CellectarBio @BeiGeneGlobal
Cellectar Biosciences retweeted
IT'S NOT TOO LATE to register for the 2022 IWMF Virtual Educational Forum. Learn from our #WM experts and ask your questions LIVE! #bloodcancerawareness #waldenstroms #iwmfevents
REGISTER NOW: tinyurl.com/iwmfevents-ed-fo…
Cellectar Biosciences retweeted
Iopofosine I-131 displayed safety & efficacy in heavily pretreated patients with B-cell malignancies in CLOVER-1 trial. Results led to the CLOVER WaM trial for #Waldenströmmacroglobulinemia patients.
Read more on how to participate: cellectar.com/clinical-studi…
@CellectarBio
Cellectar Biosciences retweeted
The median survival for #myeloma patients is 8-10 years or more now. Listen to Dr. Ailawadhi @MayoClinic discuss expanded #treatment options in myeloma management with patient advocates @theMMRF @myelomacrowd & @SparkCures.
youtube.com/watch?v=MKCKY0qT…
@CellectarBio
ALT Multiple myeloma management - Discussions for solutions @CureTalks
Cellectar Biosciences retweeted
$CLRB Proud to be a sponsor of Great Debates and Updates Hematologic Malignancies (@GreatDebatesHem) taking place in #TimeSquare beginning today! #GDUHEM2022 #bloodcancer #HematologicMalignancies #WelcometoNewYork #mmsm
Cellectar Biosciences retweeted
$CLRB Our colleagues Matt and Ben are at Great Debates & Updates Hematologic Malignancies @GreatDebatesHem. Stop by and say hello! #GDUHEM2022 #bloodcancer #mmsm #HematologicMalignancies #rarecancer #RareDisease
Cellectar Biosciences retweeted
Cellectar Biosciences Announces Positive DMC Review of Pivotal Trial of Iopofosine in Waldenstrom’s... bit.ly/3Mw5huV
Cellectar Biosciences retweeted
$CLRB Our COO Jarrod Longcor gave an engaging presentation on our PDC platform yesterday at the #NovelFormatConjugatesSummit in #Boston. #clinicaltrials #clinicalresearch #platformtechnology #Waldenstroms
